Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 120 participants.
Also called NCT01947790
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 120 participants
- Sponsor
- Registry
-
NCT01947790
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT01947790. Randomized; double masking; primary purpose treatment. Start 2013-09 (registry gives no type); primary completion 2015-07 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Pioglitazone Regress Left Ventricular Mass in Type 2 Diabetes With Ischeamia Heart Disease
- Condition
- LVM
- Condition
- Type 2 Diabetic Patients With IHD
- Condition
- Endothelial Function
- Intervention (Drug)
- pioglitazone group
- Intervention (Drug)
- Metformin group
- Lead sponsor
- Xiang Guang-da
Record details
- Record id
cardio:ct-nct01947790- Content hash
2dacf1a9cdda704d861ad7a7951276fd5263d62eab6ce671ac20c04442a16578